Amylyx Pharmaceuticals, Inc. AMLX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s short-term investments?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported short-term investments of $50.63M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s short-term investments changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s short-term investments decreased by 64.9% year-over-year, from $144.3M to $50.63M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s short-term investments?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s short-term investments has grown at a 18.4% compound annual growth rate (CAGR), from $45.93M to $90.33M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.